Comparative analyses of immune characteristics before and after the development of acquired resistance to ICI in NSCLC patients have identified various gene mutations including B2M, STK11, KEAP1, and JAK1/2 associated with resistance (91). Here, B2M is linked to non-small cell lung carcinoma.